Britain's Nuclear Deterrent Rocked by Drug Scandal – 175 Submariners Caught

Britain's nuclear deterrent has been rocked by revelations that 175 Royal Navy submariners tested positive for banned drugs over the past seven years. Ministry of Defence data released this week show the scale of the issue within the force that operates the UK's Trident nuclear weapons system. Of the 175 positives between 2018 and 2024, 52 occurred while personnel were serving aboard submarines, some of them on vessels equipped with the country's ultimate deterrent.

The random tests uncovered use of cocaine, cannabis, ecstasy, steroids and benzodiazepines, prompting questions about discipline and security in one of the military's most sensitive roles. The figures come from compulsory, unannounced testing across the nuclear submarine service.

The Extent of the Problem

The figures cover the entire nuclear submarine service, which includes crews for the four Vanguard-class vessels that form the backbone of Britain's nuclear capability. Almost all those who tested positive were discharged from the service, although a small number may have avoided punishment if they had mitigating circumstances or were unaware the substance was prohibited.

Former commanders have pointed to the intense pressures of submarine life as a contributing factor. Long patrols and limited shore time are part of the job, but some suggest they are taking a toll on mental resilience.

The service has seen one Vanguard submarine return after a record 204 days underwater last year, while availability of the Astute-class attack submarines remains a challenge. Crew shortages have become a growing headache, with the loss of even a handful of specialists stretching resources and increasing the burden on colleagues who must pick up the slack.

Security Risks for Britain's Nuclear Deterrent

Security experts have highlighted the blackmail risk posed by drug use among personnel with access to classified information. Philip Ingram, a former colonel in British military intelligence, said: 'There is no place for drugs in our Armed Forces, and especially in sensitive areas such as the submarine service where there is an increased security risk of drug-takers being blackmailed for classified and sensitive insights'.

The MoD has insisted no drugs were discovered during any submarine searches in the seven-year period. Nevertheless, the cases have raised concerns about the integrity of the nuclear deterrent, particularly as one Vanguard-class boat is always on patrol carrying Trident II missiles.

Each of the four submarines costs around £6 billion ($8 billion) and represents a significant investment in national security.

The Navy's Response and Operational Strains

A Royal Navy spokesperson emphasised the service's robust approach. 'We operate a strict zero-tolerance policy towards drug misuse,' the spokesperson said. 'Any individual found to have breached this policy can expect to face serious consequences, including immediate discharge from the service.'

All submariners undergo mandatory substance misuse training every two years. Yet the loss of trained personnel has a knock-on effect, increasing workloads for those who remain and potentially affecting operational readiness in a force already under strain from extended deployments.

As one Instagram account summarised in a recent reel, the scandal has sparked wider debate about discipline and the pressures facing those who operate Britain's nuclear deterrent. The revelations serve as a reminder of the challenges in maintaining the highest standards within the elite service responsible for the UK's strategic nuclear posture.